FAISAL ASHRAF BHAT

PhD Research Scholar (ICMR-SRF) |Department of Pharmacology, Jamia Hamdard, specialized in pharmaceutical nanotechnology and cardiac health. Developed dapagliflozin bilosomal nanocarriers for cardiac protection, and examined autophagic pathways in heart disease. Proficient in experimental techniques and data analysis, with multiple publications. Dedicated to advancing cardiovascular therapies and uncovering cellular mechanisms.

• Development and evaluation of a dapagliflozin-loaded bilosomal nanocarrier for enhanced cardioprotection in isoproterenol-induced heart failure in rats https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5292626
• Cardio-oncological dialogue: Understanding the mechanistic correlation between heart failure and cancer https://doi.org/10.1016/j.lfs.2024.123170
• Myasthenia gravis, molecular pathogenesis, and therapeutic advances https://www.taylorfrancis.com/chapters/edit/10.1201/9780429265198-14
• Therapeutic delivery of tumor suppressor miRNAs for breast cancer treatment, https://doi.org/10.3390/biology12030467
• Targeting breast cancer signaling via phytomedicine and nanomedicine, accepted in Pharmacology, Karger for publication, https://doi.org/10.1159/000531802

• GPAT (Graduate Pharmacy Aptitude Test, 2017): Scored 121 (Percentile: 98.35)
• NIPER (National Institute of Pharmaceutical Education and Research) JEE (PhD), 2019: AIR 18
• Ranked 5th in Jamia Hamdard PhD entrance, earning the prestigious SunPharma fellowship in Pharmaceutical Medicine
• Awarded ICMR-SRF 2022 through direct selection based on a research proposal addressing the need for nanocarriers in cardiovascular therapy

• Presented an oral talk on 'Drug Discovery 2025' at Jamia Millia Islamia’s Centre for Interdisciplinary Research, highlighting emerging trends and future prospects, Feb 24-26, 2025
• Participated in an advanced workshop on preclinical cardiovascular research at Jamia Hamdard, enhancing expertise in cutting-edge preclinical methodologies and cardiovascular science
• Presented a poster at the International Nanotechnology and Drug Delivery Conference (2023) and RBSRM 2022
• Presented research on SGLT2 inhibitors in heart failure at the 6th ISNSCON 2018
• AICTE-sponsored National Conference on “Pharmaceutical Regulatory Landscape: Its Key Role and Functions
• International Conference on Recent Advances in Food Fortification and Vitamin D Deficiency, September 15-16, 2018, Jamia Hamdard
• National Conference on 'Role of Clinical Pharmacist in Advancing Healthcare' — October 26-27, 2018, Amity University
• Workshop on managing research for effective outcomes — August 4, 2018, Jamia Hamdard
• Emerging dimensions in hospital healthcare management — April 4, 2019, Delhi Pharmaceutical Sciences and Research University (DPSRU)
• UGC-SAP DRS-II Seminar on 'Recent Advances in Pharmacotherapeutics' — March 28, 2019, Jamia Hamdard
• ICMR-sponsored workshop on “Nanomedical Sciences and Healthcare Challenges, Opportunities, and Future Directions” — January 7, 2019, Vigyan Bhawan, New Delhi
• 6th World Congress on Nanomedical Sciences — Presented paper: “Repurposing of SGLT2 inhibitors in heart failure”